ClassID:

95301

C07D417/12 - page 11 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#3001
20150080373
2015-03-19

Bicyclic antibiotics

#3002
20150080364
2015-03-19

Carbamate compounds and of making and using same

#3003
20150080351
2015-03-19

Aryl sulfonamides

#3004
20150080349
2015-03-19

Modulation of bacterial quorum sensing with synthetic ligands

#3005
20150073139
2015-03-12

Pesticidal arylpyrrolidines

#3006
20150072976
2015-03-12

Substituted benzamides and their uses

#3007
20150072970
2015-03-12

Biaryl heterocyclic compounds and methods of making and using the same

#3008
20150065505
2015-03-05

Pyrimidinone carboxamide inhibitors of endothelial lipase

#3009
20150065504
2015-03-05

ANTIVIRAL COMPOUNDS

#3010
20150065490
2015-03-05

ORGANIC COMPOUNDS

#3011
20150065464
2015-03-05

Amide compounds, compositions and applications thereof

#3012
20150065343
2015-03-05

Acrylamide compounds for combating invertebrate pests

#3013
20150057448
2015-02-26

Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives

#3014
20150057446
2015-02-26

Process for preparing dasatinib monohydrate

#3015
20150057289
2015-02-26

Bicyclo[3.2.1]octyl amide derivatives and uses of same

#3016
20150057285
2015-02-26

Benzyl substituted triazine derivatives and their therapeutical applications

#3017
20150057281
2015-02-26

Modulators of HEC1 activity and methods therefor

#3018
20150057272
2015-02-26

BENZIMIDAZOLES AND RELATED ANALOGS AS SIRTUIN MODULATORS

#3019
20150057271
2015-02-26

Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors

#3020
20150056284
2015-02-26

Pharmaceutical composition

#3021
20150051406
2015-02-19

PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

#3022
20150051402
2015-02-19

Thiazole methylamino pyridine compounds and preparation method therefor

#3023
20150051399
2015-02-19

Processes for preparing tubulysin derivatives and conjugates thereof

#3024
20150051249
2015-02-19

Inhibition of MCL-1 and/or BFL-1/A1

#3025
20150051233
2015-02-19

Methods and compositions for treatment of fibrosis

#3026
20150051196
2015-02-19

Inhibitors of c-fms kinase

#3027
20150051193
2015-02-19

PI-kinase inhibitors with broad spectrum anti-infective activity

#3028
20150051187
2015-02-19

Substituted pyrazines as ATR kinase inhibitors

#3029
20150051185
2015-02-19

Chemical Compounds 251

#3030
20150051177
2015-02-19

Methods and compositions useful in treating cancer and reducing WNT mediated effects in a cell

#3031
20150045402
2015-02-12

Heterocyclic acetamide compound

#3032
20150045401
2015-02-12

Prodrugs of riluzole and their method of use

#3033
20150045393
2015-02-12

Cysteine protease inhibitors and uses thereof

#3034
20150045368
2015-02-12

Oxazolidinone compounds and derivatives thereof

#3035
20150045366
2015-02-12

SPRAY DRIED FORMULATIONS

#3036
20150045344
2015-02-12

4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof

#3037
20150045340
2015-02-12

Amidine substituted -lactam compounds, their preparation and use as antibacterial agents

#3038
20150045339
2015-02-12

Nitrogen-containing heterocyclic compound or salt thereof

#3039
20150045323
2015-02-12

Prodrugs of amino quinazoline kinase inhibitor

#3040
20150038523
2015-02-05

Integrin antagonist conjugates for targeted delivery to cells expressing alpha-V-beta-3

#3041
20150038492
2015-02-05

Benzamides and nicotinamides as Syk modulators

#3042
20150038488
2015-02-05

Substituted pyrrolidines as SYK inhibitors

#3043
20150038483
2015-02-05

Aromatic 5-membered heterocyclic derivative having TRPV4-Inhibiting activity

#3044
20150038416
2015-02-05

GLP-1 receptor modulators

#3045
20150031733
2015-01-29

Tetrazolinone compounds and its use

#3046
20150031731
2015-01-29

Polymorph of a pharmaceutical

#3047
20150031730
2015-01-29

Fungicidal 3-[(1,3-thiazol-4-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2H)-one derivatives

#3048
20150031714
2015-01-29

METHODS AND COMPOSITIONS FOR PREVENTION OF ALLERGIC REACTION

#3049
20150031696
2015-01-29

Cyanoisoquinoline compounds and methods of use thereof

#3050
20150031694
2015-01-29

Antimicrobial agents

#3051
20150031686
2015-01-29

PHENYL-OXAZOLYL DERIVATIVES, PREPARATION METHOD THEREOF, AND RELATED APPLICATION OF THE PHENYL-OXAZOLYL DERIVATIVES AS AN IMPDH INHIBITOR

#3052
20150031685
2015-01-29

Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists

#3053
20150031684
2015-01-29

Sweet flavor modifier

#3054
20150031669
2015-01-29

Substituted quinoxalines as FGFR kinase inhibitors

#3055
20150031662
2015-01-29

Useful combinations of monobactam antibiotics with beta-lactamase inhibitors

#3056
20150031661
2015-01-29

Substituted pyrazin-2-amines as inhibitors of ATR kinase

#3057
20150031658
2015-01-29

Ethoxyphenyl thienyl compounds and methods for the treatment of bacterial infections

#3058
20150025235
2015-01-22

Benzamide compounds and related methods of use

#3059
20150025108
2015-01-22

8-hydroxy quinoline derivatives

#3060
20150025094
2015-01-22

Compounds and compositions for use in augmentation of glucose

#3061
20150025076
2015-01-22

Modulators of ATP-binding cassette transporters

#3062
20150025056
2015-01-22

Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases

#3063
20150025054
2015-01-22

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#3064
20150024936
2015-01-22

Fungicidal pyrimidine compounds

#3065
20150018551
2015-01-15

Cycloalkane derivatives

#3066
20150018547
2015-01-15

Aromatic ring compound

#3067
20150018543
2015-01-15

ANTI-INFECTIVE COMPOUNDS

#3068
20150018371
2015-01-15

Positive allosteric modulators for melanocortin receptors

#3069
20150018368
2015-01-15

Process for preparing benzisothiazol-3-yl-piperazin-1-yl-methyl-cyclo hexylmethanisoindol-1,3-dione and its intermediates

#3070
20150018366
2015-01-15

TRPV1 antagonists including dihydroxy substituent and uses thereof

#3071
20150018352
2015-01-15

Sulfamide sodium channel inhibitors

#3072
20150018351
2015-01-15

Methods of treatment using pyridinonyl PDK1 inhibitors

#3073
20150018338
2015-01-15

OXAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS

#3074
20150018330
2015-01-15

Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials

#3075
20150018321
2015-01-15

Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors

#3076
20150011751
2015-01-08

NOVEL TRIAZINE DERIVATIVE

#3077
20150011541
2015-01-08

PIPECOLATE-SULFONAMIDES FOR TREATMENT OF PSYCHIATRIC DISORDERS

#3078
20150011535
2015-01-08

Heterocyclic compounds, medicaments containing them, use and processes for the preparation thereof

#3079
20150011528
2015-01-08

PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#3080
20150011527
2015-01-08

GLP-1 receptor modulators

#3081
20150011002
2015-01-08

2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

#3082
20150005493
2015-01-01

Methods and intermediates for preparing pharmaceutical agents

#3083
20150005319
2015-01-01

Macrocyclic compounds for modulating IL-17

#3084
20150005297
2015-01-01

2,4-pyrimidinediamine compounds and their uses

#3085
20150005296
2015-01-01

Compounds, compositions and methods

#3086
20150005294
2015-01-01

Azaheterocyclic compounds

#3087
20150005279
2015-01-01

Primary carboxamides as BTK inhibitors

#3088
20150005276
2015-01-01

1,2,4-triazine-4-amine derivatives

#3089
20150005275
2015-01-01

Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis

#3090
20150004181
2015-01-01

Benzazole derivatives as histamine H4 receptor ligands

#3091
20140378687
2014-12-25

Synthesis for thiazolidinedione compounds

#3092
20140378510
2014-12-25

Small molecule activators of calcium-activated chloride channels and methods of use

#3093
20140378504
2014-12-25

Method of using substituted 2-Aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C

#3094
20140378445
2014-12-25

Methods for treating vascular leak syndrome

#3095
20140378444
2014-12-25

Targeted nitroxide agents

#3096
20140378442
2014-12-25

Phthalazinone derivatives

#3097
20140378421
2014-12-25

Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

#3098
20140378415
2014-12-25

Isothiazoline derivatives as insecticidal compounds

#3099
20140377292
2014-12-25

MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF USING THE SAME

#3100
20140371276
2014-12-18

TRPM8 antagonists

#3101
20140371268
2014-12-18

Biphenylcarboxamides as ROCK kinase inhibitors

#3102
20140371263
2014-12-18

Compounds and methods for the treatment of cystic fibrosis

#3103
20140371238
2014-12-18

COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

#3104
20140371236
2014-12-18

Agent for treatment of schizophrenia

#3105
20140371223
2014-12-18

NOVEL TRIAZINEDIONE DERIVATIVES AS GABAB RECEPTOR MODULATORS

#3106
20140371201
2014-12-18

Bicyclic sulfonamide compounds as sodium channel inhibitors

#3107
20140371196
2014-12-18

Diamino heterocyclic carboxamide compound

#3108
20140371194
2014-12-18

Methods for the treatment of bacterial infections

#3109
20140364608
2014-12-11

Aryloxyacetamide compound and pesticide

#3110
20140364602
2014-12-11

Methods and intermediates for preparing pharmaceutical agents

#3111
20140364465
2014-12-11

Thiazolidinedione derivatives, preparation thereof and use thereof in cancer treatment

#3112
20140364461
2014-12-11

METHOD OF TREATING DERMATOLOGICAL DISORDERS

#3113
20140364450
2014-12-11

AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES

#3114
20140364433
2014-12-11

Substituted prolines/piperidines as orexin receptor antagonists

#3115
20140364424
2014-12-11

Sulfonaminoquinoline hepcidin antagonists

#3116
20140364393
2014-12-11

Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors

#3117
20140360395
2014-12-11

Color-forming composition, color-forming curable composition, lithographic printing plate precursor and plate making method, and color-forming compound

#3118
20140357864
2014-12-04

Process for the preparation of a statin precursor

#3119
20140357675
2014-12-04

Substituted phenylazole derivatives

#3120
20140357650
2014-12-04

FAP inhibitors

#3121
20140357629
2014-12-04

Diaminopyrimidines as P2Xand P2Xantagonists

#3122
20140357624
2014-12-04

Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy

#3123
20140356322
2014-12-04

Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase

#3124
20140350056
2014-11-27

TRPV1 antagonists including dihydroxy substituent and uses thereof

#3125
20140350055
2014-11-27

Soft rock inhibitors

#3126
20140350030
2014-11-27

Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same

#3127
20140350026
2014-11-27

Oxadiazole compound and preparation method thereof, pharmaceutical composition and use thereof

#3128
20140349986
2014-11-27

Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof

#3129
20140349848
2014-11-27

Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4H)-one derivatives

#3130
20140343315
2014-11-20

Modulators of ATP-binding cassette transporters

#3131
20140343292
2014-11-20

Process for the preparation of a thioprecursor for statins

#3132
20140343278
2014-11-20

Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation

#3133
20140343073
2014-11-20

Process for preparation of amorphous form of dasatinib

#3134
20140343070
2014-11-20

Proton pump inhibitors

#3135
20140343065
2014-11-20

Somatostatin receptor subtype 4 (SSTR4) agonists

#3136
20140343049
2014-11-20

DIHYDROFURAN DERIVATIVES AS INSECTICIDAL COMPOUNDS

#3137
20140343038
2014-11-20

1,2,4-triazine-6-carboxamide derivative

#3138
20140343031
2014-11-20

N-link hydroxamic acid derivatives useful as antibacterial agents

#3139
20140343006
2014-11-20

HIV replication inhibiting pyrimidines

#3140
20140341850
2014-11-20

Haloalkyl heteroaryl benzamide compounds

#3141
20140336377
2014-11-13

Arylamide derivatives as TTX-S blockers

#3142
20140336208
2014-11-13

1,4,5,6-TETRAHYDRO-PYRIMIDIN-2-YLAMINE COMPOUNDS

#3143
20140336200
2014-11-13

Arylosulfonamides for the treatment of CNS diseases

#3144
20140336191
2014-11-13

Quinolinyloxyphenylsulfonamides

#3145
20140336185
2014-11-13

GLP-1 receptor stabilizers and modulators

#3146
20140336167
2014-11-13

NAMPT inhibitors

#3147
20140336165
2014-11-13

Dihydroxy aromatic heterocyclic compound

#3148
20140330011
2014-11-06

Certain heterocycles, compositions thereof, and methods for their use

#3149
20140330007
2014-11-06

2,4-pyrimidinediamine compounds and their uses

#3150
20140329989
2014-11-06

PREPARATION OF MICAFUNGIN INTERMEDIATES

#3151
20140329863
2014-11-06

NOVEL ANTIPRION COMPOUNDS

#3152
20140329831
2014-11-06

Dopamine D3 receptor ligands and preparation and medical uses of the same

#3153
20140329829
2014-11-06

TRPV1 antagonists including dihydroxy substituent and uses thereof

#3154
20140329796
2014-11-06

Heterocyclic amide derivative and pharmaceutical product containing same

#3155
20140329795
2014-11-06

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

#3156
20140326984
2014-11-06

Compound for organic optoelectronic element, organic light-emitting element comprising same, and display device comprising the organic light-emitting element

#3157
20140323736
2014-10-30

Use of aryl and hetaryl carboxamides as endoparasiticides

#3158
20140323486
2014-10-30

Heterocyclic urea compounds

#3159
20140323464
2014-10-30

Kinase inhibitors

#3160
20140323418
2014-10-30

SELECTIVE KINASE INHIBITORS

#3161
20140316145
2014-10-23

Compounds, compositions and methods for treatment and prevention of infections and associated diseases

#3162
20140315963
2014-10-23

Heterocyclic acetamide compound

#3163
20140315933
2014-10-23

CHEMICAL COMPOUNDS

#3164
20140315906
2014-10-23

4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group

#3165
20140315903
2014-10-23

1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors

#3166
20140315899
2014-10-23

Sulfonamides as TRPM8 modulators

#3167
20140315895
2014-10-23

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#3168
20140315721
2014-10-23

Pesticidal compositions and processes related thereto

#3169
20140314785
2014-10-23

Compositions and methods for inhibition of the JAK pathway

#3170
20140309427
2014-10-16

Substituted pyran derivatives

#3171
20140309246
2014-10-16

Methods and use of bifunctional enzyme-building clamp-shaped molecules

#3172
20140309231
2014-10-16

Substituted quinoxalines

#3173
20140309209
2014-10-16

Pyrazine kinase inhibitors

#3174
20140309185
2014-10-16

Inhibiting G protein coupled receptor 6 kinase polypeptides

#3175
20140309116
2014-10-16

Substituted 1,2,5-oxadiazole compounds and their use as herbicides II

#3176
20140303218
2014-10-09

Nitrogen mustard derivatives

#3177
20140303171
2014-10-09

HIV protease inhibitors

#3178
20140303157
2014-10-09

Metalloenzyme inhibitor compounds

#3179
20140303154
2014-10-09

2,4-pyridinediamine compounds and their uses

#3180
20140303152
2014-10-09

BENZOTHIAZINETHIONE DERIVATIVES AND PREPARATION METHODS AND USES THEREOF

#3181
20140303143
2014-10-09

Benzoxazolinone compounds with selective activity in voltage-gated sodium channels

#3182
20140303026
2014-10-09

Compounds for modulating integrin CD11B/CD18

#3183
20140296531
2014-10-02

Semi-synthetic small molecules for the treatment parasitic disease

#3184
20140296515
2014-10-02

ALKYLAMINE-SUBSTITUTED DICYANOPYRIDINE AND AMINO ACID ESTER PRODRUGS THEREOF

#3185
20140296295
2014-10-02

2-alkoxy-substituted dicyanopyridines and their use

#3186
20140296247
2014-10-02

Heterocyclic compounds and uses thereof in the treatment of sexual disorders

#3187
20140296245
2014-10-02

Benzenesulfonamide compounds and their use as therapeutic agents

#3188
20140296222
2014-10-02

Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use

#3189
20140296221
2014-10-02

Iminothiadiazine dioxide compounds as brace inhibitors, compositions, and their use

#3190
20140296202
2014-10-02

Substituted piperidinyl compounds useful as GPR119 agonists

#3191
20140288302
2014-09-25

ACETIC ACID AMIDE DERIVATIVE HAVING INHIBITORY ACTIVITY ON ENDOTHELIAL LIPASE

#3192
20140288301
2014-09-25

TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

#3193
20140288106
2014-09-25

Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists

#3194
20140288081
2014-09-25

Therapeutic compounds and compositions

#3195
20140288065
2014-09-25

N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors

#3196
20140288041
2014-09-25

Aryl- or heteroaryl-substituted benzene compounds

#3197
20140275711
2014-09-18

1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof

#3198
20140275524
2014-09-18

Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto

#3199
20140275224
2014-09-18

CYTOSINE DEAMINASE MODULATORS FOR ENHANCEMENT OF DNA TRANSFECTION

#3200
20140275180
2014-09-18

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same

#3201
20140275179
2014-09-18

GPR120 agonists for the treatment of type II diabetes

#3202
20140275159
2014-09-18

Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C

#3203
20140275155
2014-09-18

Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C

#3204
20140275103
2014-09-18

Compositions, formulations and methods for treating ocular diseases

#3205
20140275059
2014-09-18

DNA-PK inhibitors

#3206
20140275058
2014-09-18

Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use

#3207
20140275047
2014-09-18

Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto

#3208
20140275032
2014-09-18

Aryl sulfamide and sulfamate derivatives as RORc modulators

#3209
20140275028
2014-09-18

1,2,5-substituted benzimidazoles as FLAP modulators

#3210
20140275024
2014-09-18

Substituted quinoxaline DNA-PK inhibitors

#3211
20140275003
2014-09-18

Biaryl amide compounds as kinase inhibitors

#3212
20140273214
2014-09-18

Stem cell cultures

#3213
20140256939
2014-09-11

PROCESS OF PREPARING A QUATERNARY AMMONIUM SALT USING PHOSPHATE

#3214
20140256771
2014-09-11

COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM

#3215
20140256753
2014-09-11

Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections

#3216
20140256744
2014-09-11

Polycyclic compounds as lysophosphatidic acid receptor antagonists

#3217
20140256736
2014-09-11

Biaryl ether sulfonamides and their use as therapeutic agents

#3218
20140256715
2014-09-11

Oxazine derivatives and their use in the treatment of disease

#3219
20140256707
2014-09-11

Heteroaryl sodium channel inhibitors

#3220
20140249316
2014-09-04

Isoxazoline derivatives as insecticides

#3221
20140249315
2014-09-04

PROCESSES FOR PREPARING TUBULYSINS

#3222
20140249306
2014-09-04

HIV replication inhibitor

#3223
20140249201
2014-09-04

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

#3224
20140249154
2014-09-04

SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF CANCERS, INCLUDING HEPATOCELLULAR CARCINOMA, AND AS INHIBITORS OF HEPATITIS VIRUS REPLICATION

#3225
20140249144
2014-09-04

Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient

#3226
20140249100
2014-09-04

Compounds, compositions, and methods for preventing metastasis of cancer cells

#3227
20140248252
2014-09-04

New Salt And Medical Use

#3228
20140243529
2014-08-28

Process for the preparation of lurasidone hydrochloride

#3229
20140243524
2014-08-28

Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

#3230
20140243377
2014-08-28

DEUTERIUM-ENRICHED PIOGLITAZONE

#3231
20140243366
2014-08-28

Compounds that modulate intracellular calcium

#3232
20140243340
2014-08-28

CYTOCHROME P450 OXIDASE INHIBITORS AND USES THEREOF

#3233
20140243338
2014-08-28

Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors

#3234
20140243333
2014-08-28

SYNTHESIS OF FUNCTIONALIZED OCTAHYDRO-ISOQUINOLIN-1-ONE-8-CARBOXYLIC ESTERS AND ANALOGS, AND THERAPEUTIC METHODS

#3235
20140243325
2014-08-28

1,3-oxazines as BACE1 and/or BACE2 inhibitors

#3236
20140243314
2014-08-28

Quinolinone carboxamide inhibitors of endothelial lipase

#3237
20140243305
2014-08-28

Azetidinyl diamides as monoacylglycerol lipase inhibitors

#3238
20140243292
2014-08-28

SUBSITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS

#3239
20140243290
2014-08-28

Aminopyrimidines as SYK Inhibitors

#3240
20140242120
2014-08-28

SUBSTITUTED AROMATIC COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES

#3241
20140242026
2014-08-28

Compounds, compositions, and methods for preventing metastasis of cancer cells

#3242
20140235863
2014-08-21

SUBSTITUTED 4-ARYLTHIAZOLES AND PROCESS OF PREPARATION THEREOF

#3243
20140235646
2014-08-21

Methods and compositions for the treatment of body weight related disorders

#3244
20140235624
2014-08-21

Sweet flavor modifier

#3245
20140235623
2014-08-21

Modulation of chemosensory receptors and ligands associated therewith

#3246
20140235622
2014-08-21

Primary amines and derivatives thereof as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto

#3247
20140235613
2014-08-21

SUBSTITUTED DIARYL AZETIDINE DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS

#3248
20140235608
2014-08-21

Pyridinedione carboxamide inhibitors of endothelial lipase

#3249
20140235440
2014-08-21

Pesticidal compositions and processes related thereto

#3250
20140234939
2014-08-21

Benzamide compounds and related methods of use

#3251
20140234333
2014-08-21

Compositions and methods for inhibition of the JAK pathway

#3252
20140228416
2014-08-14

Substituted hydroxamic acids and uses thereof

#3253
20140228408
2014-08-14

Rock kinase inhibitors

#3254
20140228371
2014-08-14

Substituted quinoxalines as sodium channel modulators

#3255
20140228367
2014-08-14

Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors

#3256
20140228363
2014-08-14

TETRASUBSTITUTED CYCLOHEXYL COMPOUNDS AS KINASE INHIBITORS

#3257
20140228343
2014-08-14

PRMT5 inhibitors and uses thereof

#3258
20140228321
2014-08-14

Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors

#3259
20140227320
2014-08-14

Anti-viral compounds

#3260
20140221653
2014-08-07

Prodrugs of NH-acidic compounds

#3261
20140221616
2014-08-07

Haptens of quetiapine

#3262
20140221481
2014-08-07

Sulfur derivatives as chemokine receptor modulators

#3263
20140221433
2014-08-07

N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate

#3264
20140221421
2014-08-07

Therapeutic compounds

#3265
20140221373
2014-08-07

Arylpyrazole ethers as inhibitors of leukotriene A4 hydrolase

#3266
20140221369
2014-08-07

5-DEUTERO-2,4-THIAZOLIDINEDIONE AND 5-DEUTERO-2,4-OXAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME

#3267
20140221360
2014-08-07

USE OF AMINODIHYDROTHIAZINES FOR THE TREATMENT OR PREVENTION OF DIABETES

#3268
20140221357
2014-08-07

Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors

#3269
20140221351
2014-08-07

NOVEL 1,2- BIS-SULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS

#3270
20140221345
2014-08-07

PRMT5 inhibitors and uses thereof

#3271
20140221339
2014-08-07

Heterocyclic derivative and pharmaceutical drug

#3272
20140221310
2014-08-07

Flap modulators

#3273
20140213611
2014-07-31

Benzylamine derivatives as inhibitors of plasma kallikrein

#3274
20140213581
2014-07-31

Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereof

#3275
20140206879
2014-07-24

Dipeptoid prodrugs and their use

#3276
20140206701
2014-07-24

SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF

#3277
20140206699
2014-07-24

Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease

#3278
20140206691
2014-07-24

Cyclic protein tyrosine kinase inhibitors

#3279
20140206688
2014-07-24

Amino quinazolines as kinase inhibitors

#3280
20140206686
2014-07-24

Substituted phthalazinones as rock inhibitors

#3281
20140206675
2014-07-24

Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use

#3282
20140206668
2014-07-24

Pesticidal compositions and processes related thereto

#3283
20140206661
2014-07-24

Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions

#3284
20140200213
2014-07-17

2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use

#3285
20140200212
2014-07-17

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

#3286
20140200197
2014-07-17

HIV protease inhibitors

#3287
20140194436
2014-07-10

Heteroarylmethyl amides

#3288
20140194424
2014-07-10

Spirolactam derivatives and uses of same

#3289
20140194412
2014-07-10

Thioxothiazolidine derivative having Ras function inhibitory effect

#3290
20140194402
2014-07-10

Pyruvate kinase activators for use in therapy

#3291
20140193906
2014-07-10

Screening methods for spinal muscular atrophy

#3292
20140187781
2014-07-03

AMINOPYRIDINES AND AMINOPYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES

#3293
20140187592
2014-07-03

Nitrogen-containing aromatic heterocyclyl compound

#3294
20140187536
2014-07-03

AGENTS FOR PREVENTING AND TREATING DISORDERS INVOLVING MODULATION OF THE RYANODINE RECEPTORS

#3295
20140179922
2014-06-26

Intermediate compounds and process for the preparation of lurasidone and salts thereof

#3296
20140179735
2014-06-26

Tyrosine phosphatase inhibitors and uses thereof to modulate the activity of enzymes involved in the pathology of

#3297
20140179709
2014-06-26

Antiviral agents

#3298
20140179693
2014-06-26

METHODS FOR TREATING VASCULAR LEAK SYNDROME

#3299
20140179689
2014-06-26

Rho kinase inhibitors and methods of use

#3300
20140171639
2014-06-19

TRPM8 antagonists and their use in treatments